Schedule 2 Controlled Drugs: What Prescribers Need to Know

Understanding the Controlled Drug Prescription Requirements

• Prescriptions for Schedule 2 drugs must be handwritten or generated by an approved system
• The prescription must include the total quantity in both words and figures
• A maximum of 30 days supply is the standard limit for Schedule 2 medicines
• Instalment prescribing requires specific Home Office authority in most circumstances

Prescribing Schedule 2 controlled drugs carries additional legal obligations that go beyond standard prescription requirements. For medical cannabis clinicians, familiarity with the Misuse of Drugs Regulations 2001 and associated NHS guidance is essential from day one of prescribing practice.

Record-Keeping and Audit Obligations

• A controlled drug register must record every receipt and supply transaction
• Entries must be made on the day of the transaction or the following day
• Registers must be retained for at least two years from the last entry
• Private prescribers must submit controlled drug prescription data under certain thresholds

The controlled drug register is a legal document subject to inspection by the MHRA, NHS Controlled Drug Accountable Officers, and the Care Quality Commission. Incomplete or inaccurate records are a common finding during regulatory inspections and can result in formal enforcement action even where no patient harm has occurred.

Safe Custody and Storage Requirements

• Schedule 2 cannabis medicines must be stored in a locked controlled drugs cabinet
• Cabinets must comply with BS EN 14450 or equivalent security standards
• Access should be restricted to authorised personnel only
• Regular stock checks are best practice and often a regulatory expectation

Safe custody requirements exist to prevent diversion of controlled drugs from the legitimate supply chain. Clinics and pharmacies dispensing medical cannabis must ensure their storage arrangements are compliant before receiving their first consignment. MHRA and CQC inspectors will examine storage facilities as a matter of course.

Travelling with Medical Cannabis Prescriptions

• Patients travelling within the UK may carry their prescribed supply without additional documentation
• International travel requires a personal licence from the Home Office for most jurisdictions
• The UK has bilateral arrangements with some countries but not all EU member states
• Clinicians should advise patients to seek guidance well in advance of international travel

One of the most common queries clinicians receive from medical cannabis patients concerns travel. The legal status of cannabis-based medicines varies enormously between countries, and assumptions based on UK law do not translate abroad. Proactive guidance from the prescribing clinician reduces the risk of patients inadvertently committing serious criminal offences overseas.